VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma.

International journal of oncology

Volumn 16, Issue 4, 2000, Pages 777-782

  El Helw, L M ^a   Lorigan, P C ^a   Robinson, M H ^a   Coleman, R E ^a   Hancock, B W ^a  

^a WESTON PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEXAMETHASONE; EPIRUBICIN; VINCRISTINE;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; NONHODGKIN LYMPHOMA; PALLIATIVE THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; EPIRUBICIN; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PALLIATIVE CARE; VINCRISTINE;

MLCS; MLOWN;

EID: 0034164542     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.16.4.777     Document Type: Article

References (0)